New App-Based study tracks Real-Life impact of melanoma combo therapy
Knowledge-focused
Ongoing
This study follows 50 adults in the UK with advanced melanoma who are starting a two-drug treatment (encorafenib and binimetinib). Instead of testing if the drugs work, researchers want to see how the treatment affects patients' daily lives and well-being over two years. Particip…
Sponsor: Pierre Fabre Ltd • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC